EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uncovering the molecular landscape of young-onset diffuse gastric cancer: A relieff-based feature selection analysis on RNA-Seq data

Zahra Khalili Azni, Matia Sadat Borhani iD, Hossein Sabouri, Sayed Javad Sajadi iD, Maryam Pasandideh Arjmand iD

PLOS One · 06.08.2026 · 21 (8) · e0354961

DOI: 10.1371/journal.pone.0354961 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.08.2026. Verfasst von Zahra Khalili Azni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Basic Sciences and Engineering, Gonbad Kavous University, Gonbad Kavous, Golestan, Iran. Hauptthemen laut MEDLINE: Stomach Neoplasms, RNA-Seq. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diffuse Gastric Cancer (DGC) is an aggressive subtype with a poor prognosis and a lack of specific biomarkers, representing a critical unmet need in oncology. This study aimed to elucidate the key molecular drivers of DGC by integrating RNA-seq data with a multi-faceted bioinformatics approach.

Methods

We analyzed RNA-seq data from young-onset DGC and normal tissues (GSE113255, GSE122401). Machine learning (ML) feature selection (ReliefF algorithm) was used to prioritize genes, followed by protein-protein interaction network analysis to identify hub genes. Their roles were further investigated through Gene Ontology, KEGG pathway analysis, tumor microenvironment immune infiltration, miRNA-regulatory network analysis, transcription factor prediction, and computational drug repurposing analyses.

Results

Our ML‑driven approach identified seven hub genes central to DGC pathogenesis including CCL5 , CXCR4 , MMP9 , FOXP3 , IL18 , TNFSF11 , and TNFSF13B . Among these, three prioritized core hub genes ( CXCR4 , MMP9 , and TNFSF13B ) were selected based on statistically significant overexpression and complementary functional roles. Specifically, CXCR4 showed a Fold Change of 3.12 (Log 2 FC = 1.64, FDR = 0.01), MMP9 exhibited the highest magnitude of upregulation (Fold Change = 16.58, Log 2 FC = 4.05), and TNFSF13B demonstrated the most statistically significant differential expression (Fold Change = 2.32, Log 2 FC = 1.21, FDR < 0.000001). High CXCR4 expression was identified as a potential prognostic indicator associated with poorer overall survival in the TCGA‑STAD cohort (HR = 1.5, p = 0.0072). We delineated a core regulatory circuitry where NF‑κB (NFKB1/RELA) masterfully regulates the hub gene network. Drug repurposing analysis nominated several FDA‑approved agents, including the VEGF‑A inhibitor Bevacizumab, which indirectly suppresses CXCR4 and MMP9 .

Conclusion

This pilot study establishes a robust integrative framework that synergizes ML with network biology. It nominates CXCR4 and TNFSF13B as candidate therapeutic targets and highlights the potential of ML‑based feature selection for discovering biologically relevant, context‑dependent prognostic indicators in DGC. However, we emphasize that these findings are exploratory and hypothesis‑generating, requiring independent validation through experimental studies and larger cohorts before any clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsRNA-SeqHumansGene Expression Regulation, NeoplasticMachine LearningGene Regulatory NetworksProtein Interaction MapsComputational BiologyTumor MicroenvironmentPrognosisMicroRNAsBiomarkers, TumorGene Expression ProfilingAlgorithmsReceptors, CXCR4

Substanzen

MicroRNAsBiomarkers, TumorReceptors, CXCR4CXCR4 protein, human

Autor:innen und Institutionen

  • Department of Biology, Faculty of Basic Sciences and Engineering, Gonbad Kavous University, Gonbad Kavous, Golestan, Iran.
  • Department of Plant Production, Faculty of Agriculture Sciences and Natural Resources, Gonbad Kavous University, Gonbad Kavous, Golestan, Iran.
  • Department of Plant Biotechnology, Faculty of Agricultural Sciences, University of Guilan, Rasht, Guilan, Iran.
  • Researcher, BioGenTAC lnc., Technology Incubator of Agricultural Biotechnology Research Institute of Iran-North Branch (ABRII), Rasht, Guilan, Iran.

ORCID-Profile: Matia Sadat Borhani, Sayed Javad Sajadi, Maryam Pasandideh Arjmand

Zitieren

APA

Azni, Z. K., Borhani, M. S., Sabouri, H., Sajadi, S. J., & Arjmand, M. P. (2026). Uncovering the molecular landscape of young-onset diffuse gastric cancer: A relieff-based feature selection analysis on RNA-Seq data. PLOS One, 21(8), e0354961. https://doi.org/10.1371/journal.pone.0354961

Vancouver

Azni ZK, Borhani MS, Sabouri H, Sajadi SJ, Arjmand MP. Uncovering the molecular landscape of young-onset diffuse gastric cancer: A relieff-based feature selection analysis on RNA-Seq data. PLOS One. 2026;21(8):e0354961. doi:10.1371/journal.pone.0354961

BibTeX
@article{Azni2026,
  author = {Azni, Zahra Khalili and Borhani, Matia Sadat and Sabouri, Hossein and Sajadi, Sayed Javad and Arjmand, Maryam Pasandideh},
  title = {Uncovering the molecular landscape of young-onset diffuse gastric cancer: A relieff-based feature selection analysis on RNA-Seq data},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0354961},
  doi = {10.1371/journal.pone.0354961}
}
Kostenlos starten →